Zhen Lin

Zhen Lin is a patent litigator whose practice focuses on the pharmaceutical and biotechnology sectors. Lin has primarily represented plaintiffs in patent infringement cases.

Lin is currently an attorney at Paul, Weiss, Rifkind, Wharton & Garrison LLP. Previously, Lin was associated with Weil, Gotshal & Manges LLP.

A notable case in Lin's experience is Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., where Lin served as Lead Counsel for the plaintiff, Regeneron Pharmaceuticals. This case involved a dispute over 25 patents covering Regeneron's EYLEA® (aflibercept) formulations and biologics manufacturing against Celltrion's biosimilar candidate. The case was ultimately dismissed without prejudice by joint stipulation of the parties, leaving open the possibility for future litigation.

While specific details about Lin's PTAB or IPR experience are not extensively detailed in the provided search results, their involvement in high-stakes pharmaceutical patent litigation suggests familiarity with the broader landscape of patent challenges. Lin is admitted to the New York bar and holds a J.D. from the University of Toronto Faculty of Law, an M.Sc. from the University of Toronto, and a B.S. from the University of Guelph.